What is the ticker symbol for Werewolf Therapeutics?

Werewolf Therapeutics trades under the ticker HOWL on NASDAQ.

What sector does Werewolf Therapeutics operate in?

Werewolf Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze HOWL in a portfolio?

PortView shows HOWL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Werewolf Therapeutics (HOWL) Stock Analysis

NASDAQHealthcareBiotechnology

$0.96-0.10%

1-year price historyRange $0.31 – $2.19

52-week range$0.96

$0.27$2.38

What Werewolf Therapeutics does

Werewolf Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing novel therapies that activate the body's immune system to combat cancer. Leveraging its exclusive PREDATOR platform, the company crafts conditionally activated molecules designed to stimulate both adaptive and innate immunity. This strategic approach aims to circumvent the shortcomings often associated with traditional proinflammatory immune treatments. Key among its product pipeline are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule targeting advanced solid tumors, and WTX-330, an Interleukin-12 INDUKINE molecule also designed for conditional activation, intended for advanced or metastatic solid tumors or lymphomas that have relapsed or are refractory. Furthermore, Werewolf Therapeutics is progressing WTX-613, a conditionally activated interferon alpha INDUKINE molecule, for addressing solid tumors and hematologic malignancies. The company was founded in 2017 and operates from its headquarters in Cambridge, Massachusetts.

Key metrics

Market cap

$46.48M

P/E (TTM)

-1.26

EPS (TTM)

$-0.76

Beta

0.29

Dividend yield

0.00%

Revenue / share

$0.43

50-day avg

$0.47

200-day avg

$0.65

52-week high

$2.38

52-week low

$0.27

CEO

Daniel J. Hicklin

ETFs linked to HOWL

Broad-market and Healthcare sector ETFs an investor holding Werewolf Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how HOWL fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze HOWL in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Werewolf Therapeutics?: Werewolf Therapeutics trades under the ticker HOWL on NASDAQ.
Which exchange is HOWL listed on?: HOWL is listed on NASDAQ.
What sector does Werewolf Therapeutics operate in?: Werewolf Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze HOWL in a portfolio?: PortView shows HOWL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.